Phocas Financial Corp’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
AC
RA
BH
WCM
Phocas Financial Corp's ANGO Position: Q2 2026 in Review
Phocas Financial Corp reduced its AngioDynamics (ANGO) stake by 5.1% in Q2 2026, selling an estimated $178K and leaving 292,510 shares worth $3.81M. The position accounts for 0.53% of the portfolio, ranked #79.
Phocas Financial Corp first reported a position in ANGO in Q1 2025 and has held it in 6 quarters since. The position peaked at $7.78M in Q4 2025. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.
- Phocas Financial Corp held 292,510 shares of AngioDynamics worth $3.81M as of Q2 2026.
- Phocas Financial Corp sold 15,636 AngioDynamics shares in Q2 2026, an estimated $178K.
- AngioDynamics made up 0.53% of Phocas Financial Corp's portfolio in Q2 2026, its #79 holding.
- Phocas Financial Corp first reported a position in AngioDynamics in Q1 2025 and has held it in 6 quarters since.
- Phocas Financial Corp's AngioDynamics position peaked at $7.78M in Q4 2025.
- 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.
Based on Phocas Financial Corp's 13F filing for Q2 2026, filed 31 Jul 2026.